On 15 January, the two agencies released respective lists of medicines approved last year. The FDA approved 50 novel drugs ...

General Manager and CEO of Junshi Biosciences, Dr. Jianjun ZOU, said, “Toripalimab has made significant strides in its internationalization. As of today, toripalimab has been approved in 35 countries ...

AstraZeneca Pharma India rose 1.10% to Rs 10,754 after the firm received approval from the Central Drugs Standard Control Organisation (CDSCO) to import pharmaceutical formulations of eculizumab ...

A new storage technique can keep protein-based drugs and vaccines stable without keeping them cold. The discovery, led by researchers at Penn State, could eliminate the need for refrigeration for ...

According to a cross-sectional study, mothers who took antidepressants or anti-inflammatory medications had lower levels of ...

Eculizumab, a monoclonal antibody, is indicated for the treatment of two rare and life-threatening conditions: Paroxysmal ...

Current treatments for dermatomyositis include various immunosuppressants and immunosuppressive agents, including ...

According to Inan’s team: “There is no documented production process of atezolizumab biosimilar in the literature except one ...

Shares of biotech Summit Therapeutics (NASDAQ: SMMT) skyrocketed 583.7% in 2024, according to data from S&P Global Market ...

The market will grow as a result of the increasing incidence of amyloidosis, technological advancements in diagnostics, ...

Windward Bio has landed with a flurry of announcements, circling in a $200 million series A and offering up to $970 million ...